30 closest matches · ranked by relevance
Pancreatic Cancer · Lymphadenopathy · Gastrointestinal Stromal Tumor
Primary: Diagnostic Yield of EUS-FNB and EUS-FNA — 67.1; 90 percentage of patients
Non-alcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis
Primary: Median Total Specimen Length — 8; 14; 8; 11.5 mm
Abdominal Neoplasms
Primary: Capability of Performing EUS-FNTA Through the Duodenum by Placing the Target Lesion in the Proper Position With Insertion of the Needle Into the Lesion — 228 Participants
Pancreatic Cancer
Primary: Total DNA Yield of Adenocarcinoma — 5930.10; 3365.22 ng/µL — p=0.01
Pancreatic Masses · Lymph Nodes
Primary: Diagnostic Accuracy — 237; 263 Participants
Pancreatic Neoplasm
Primary: Diagnostic Accuracy — 84 Diagnostic accuracy (%)
EUS Guided Biopsy
Primary: Is the Acquire Needle Non-inferior Compared to SharkCore Needle in Histologic Yield of the Sample Obtained? — 3; 4; 10; 14 Lesions
Crohn Disease · Rectal Fistula
Primary: Number of Participants With Durable Fistula Healing — 7; 8 participants
Biopsy, Fine-Needle · Biopsy, Fine-Needle/Methods · Endosonography
Primary: Compare Adequacy of Diagnoses in Passes With and Without a Stylet — 80; 68; 21; 18 passes
Pulmonary Lesions · Pulmonary Nodules · Pulmonary Mass
Primary: Diagnostic Yield of Procedures; Number of Positive Diagnosis of Pulmonary Lesions — 51; 62; 58; 51 participants
Pancreatic Duct Stone · Pancreatic Duct Stricture · Pancreatic Duct Dilatation
Primary: Percent Change in Average Daily Pain Score on the Numeric Rating Scale — -36.6; -53.7 Percent Change
GIST
Primary: Diagnostic Accuracy. — 88; 62 Percentage of participants
Pancreatic Solid Lesions · Pancreatic Mass
Primary: Diagnostic Yield of Capillary Technique — 75.4 percentage of specimen
Pancreatic Cysts
Primary: Prevalence of Pancreatic Cysts During Routine EUS — 46 participants found to have a cyst
Cancer of Pancreas · Pancreatic Neoplasm
Primary: Median Number of Passes to Establish Diagnosis — 1; 1 No. of passes
Obesity · Non-Alcoholic Steatohepatitis
Primary: Weight Loss Achieved With Intragastric Balloon (IGB) — 17 Participants
Diagnoses Diseases · Ultrasound Therapy; Complications · Liver Diseases
Primary: Number of Specimens for Which a Histologic Diagnosis Could be Made Based Upon the Amount of Tissue Obtained With the Needle — 17; 14 specimens
Pancreatic Neoplasm
Primary: Compare the Median Number of Passes Required to Establish a Diagnosis — 1; 1 No. of passes for diagnosis
Pancreatic Cancer
Primary: Procedure Duration Required for Placing the Fiducial Markers — 16; 9 mintues
Neoplasms, Cystic, Mucinous, and Serous
Primary: Number of Participants With Adverse Events as a Measure of Safety and Tolerability — 7; 16 participants
Abnormal Liver Function
Primary: Pre-processing Length of the Longest Piece (LLP) — 1.47; 2.09 centimeter
Chronic Pancreatitis · Acute Recurrent Pancreatitis
Primary: EUS Pancreatic Findings- Rosemont Criteria — 36; 0; 26; 0 percentage of participants
Pancreatic Cysts
Primary: Sensitivity — 59 percentage of participants
Disorders of the Pancreas and Biliary Tree
Primary: Successful Procedure Completion — 70; 5 participants
Chronic Liver Disease · Advanced Fibrosis · Advanced Cirrhosis
Primary: Median Endoscopic Ultrasound (EUS) Shear Wave Elastography — 0.11 kPA
Pancreatic Cystic Lesions
Primary: Volume of Aspirated Cyst Fluid as a Function of Estimated Maximal Volume — 78; 74; 73 percentage of cyst volume aspirated — p=0.84
Barrett's Esophagus
Primary: Median Tolerability Score on 10-point Visual Analog Scale (VAS) — 7; 8; 8; 8 units on a scale
Esophageal Neoplasms
Primary: Accuracy — 89; 70 Percentage of accuracy
Pancreatic Pseudocyst
Primary: Number of Participants With Clinical Success — 33 participants — p=0.05
Pancreatic Cancer
Primary: The Change in Mean Pain Scale Rating in Patients Following Treatment With 10mL or 20mL of Alcohol Injection — 7.9; 8.4 units on a scale